Best HealthTech Companies in San Diego, United States
The 437 best HealthTech companies in San Diego, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: AMN Healthcare.
Our analysis of 305 HealthTech companies
$32.1b in tracked funding; 95% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best HealthTech companies in San Diego
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | AMN Healthcare Provider of medical staffing services | $1.4B | 80 mo ago | 4,230 4,230 → 6,829 (+61%) · sector median -4% | 1985 | — | — | 1 award |
| 2 | ResMed Therapeutic devices to treat sleep apnea and respiratory disorders | $500M | 83 mo ago | 10,140 10,140 → 9,071 (-11%) · sector median -4% | 1989 | Michael Farrell Chief Executive Officer | 346 patents Advanced CPAP/BiPAP devices with smart humidification, mask fit analytics, and cloud data management | 1 internship · 1 launch · 1 award |
| 3 | Human Longevity Provider of precision medicine, preventative health assessments, and longevity care | $409M | 21 mo ago | 85 | 2013 | J Venter Co-Founder & CEO | 71 patents AI-driven multi‑omic analytics for disease risk assessment, diagnosis, and genomic trait prediction | 1 launch · 1 partnership |
| 4 | Cue Health Provider of health monitoring system for diagnosing diseases like influenza | $406M | 61 mo ago | 726 | 2010 | — | 123 patents Rapid point‑of‑care molecular diagnostics and sample collection devices for analyte detection | — |
| 5 | Iambic Therapeutics Provider of AI-driven drug discovery platform for the treatment of cancer 60Funding top 15%AI top 26%Moat top 31%Talent top 38% All 9 signals ▾Fundingtop 15% AItop 26% Moattop 31% Talenttop 38% Growthtop 45% Marketbottom 43% Newsbottom 43% Techbottom 40% Globalbottom 39% Funding: Raised $206M across 5 rounds · 5 rounds over 5 yrs (1.0/yr) AI: Classified as an AI company · Product described with: ai driven, ai-driven rank vs industry peers · Fliar Intelligence Index 60/100 | $206M | 2 mo ago | 50 | 2019 | Fred Manby Co-Founder & CTO | — | — |
| 6 | Truvian Developer of automated benchtop blood testing system for labs | $206M | 23 mo ago | 106 106 → 108 (+2%) · sector median -4% | 2015 | Dena Marrinucci Co-Founder & COO | — | — |
| 7 | Biolinq Provider of a wearable biosensor platform for diabetes monitoring 67Innovation top 13%Funding top 17%Patents top 17%Moat top 26% All 10 signals ▾Innovationtop 13% Fundingtop 17% Patentstop 17% Moattop 26% Talenttop 38% Growthtop 45% Marketbottom 45% Globalbottom 43% Techbottom 39% Newsbottom 18% Innovation: 189 patents (top 11% of patent-holders) · 161 filings since 2022 vs 28 in 2017-21 Funding: Raised $175M across 15 rounds · 15 rounds over 12 yrs (1.2/yr) rank vs industry peers · Fliar Intelligence Index 67/100 | $175M | 15 mo ago | 91 | 2012 | Jared Tangney Co-Founder | 189 patents Minimally invasive microneedle-based continuous biosensing for interstitial fluid analytes | — |
| 8 | PatientSafe Solutions Smart Point-of-Care Mobile Solutions for Healthcare organizations | $149M | 104 mo ago | 63 | 2002 | — | 23 patents Wearable barcode-scanning jackets integrating handheld medical devices and hospital displays. | — |
| 9 | Genalyte Real-time blood diagnostics at the point of care | $142M | 65 mo ago | 113 113 → 94 (-17%) · sector median -4% | 2007 | — | 47 patents Optical biosensor platforms enabling multiplexed biochemical and nucleic‑acid diagnostics | — |
| 10 | Expansion Therapeutics Provider of a software system for the development of drugs | $140M | 56 mo ago | 20 | 2016 | Matthew Disney Co-Founder | — | — |
| 11 | Awarepoint Real-time location systems for healthcare, enhancing safety and efficiency | $105M | 105 mo ago | 104 | 2002 | — | 110 patents Indoor Bluetooth Low Energy positioning and rapid access control systems | — |
| 12 | Zerigo Health Developer of UVB light therapy devices for monitoring Psoriasis, Vitiligo, and Eczema | $75M | 55 mo ago | 37 | 2014 | Lisa R CEO | — | 4 job openings |
| 13 | PetDx Developer of liquid biopsy technology for detection of cancer in dogs | $72M | 57 mo ago | 102 | 2019 | Daniel Grosu Co-Founder & CEO | 11 patents Liquid biopsy fragmentomics for cancer detection and monitoring, including mitochondrial DNA analysis | — |
| 14 | Conatus Pharma Canadian online pharmacy providing affordable medications with expert support and secure delivery | $67M | 113 mo ago | 22 | 2005 | Steven Mento CEO | — | — |
| 15 | AristaMD Provider of specialist e-consults and referral platform for healthcare providers | $62M | 51 mo ago | 37 37 → 82 (+122%) · sector median -4% | 2014 | Keith Pinter Chief Executive Officer | — | — |
| 16 | Turquoise Online platform for employee health benefits 45Funding top 19%Moat top 39%Tech bottom 49%Talent bottom 49% All 8 signals ▾Fundingtop 19% Moattop 39% Techbottom 49% Talentbottom 49% Growthbottom 48% Marketbottom 44% Newsbottom 37% Globalbottom 37% Funding: Raised $55.0M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) Moat: Editorial + unicorn rating 7/10 · 10 curated direct competitors tracked rank vs industry peers · Fliar Intelligence Index 45/100 | $55M | 3 mo ago | 52 | 2020 | Chris Severn Co-Founder & CEO | — | — |
| 17 | Dexcom Provider of a wearable device for glucose monitoring | $53M | 74 mo ago | 9,600 9,600 → 8,782 (-9%) · sector median -4% | 1999 | Kevin Sayer CEO & President | 4,656 patents Continuous glucose monitoring sensors, data transmission, and glycemic management software | — |
| 18 | Belharra Provider of photoaffinity-based chemoproteomics platform for drug discovery | $50M | 41 mo ago | 56 | 2021 | Jeff Jonker CEO | — | — |
| 19 | 1859 Provider of DNA encoded libraries for drug discovery and development | $50M | 54 mo ago | 73 | 2019 | Devon Cayer Co-Founder & CEO | 30 patents High-throughput microfluidic bioassay platforms for drug and biomolecule screening | — |
| 20 | GlySens Implantable Continuous glucose monitoring device | $47M | 72 mo ago | 29 | 1997 | William Markle CEO | 70 patents Continuous implantable glucose monitoring with integrated insulin delivery error correction | — |
| 21 | ForeSee Medical Decision support solutions for healthcare professionals | $44M | 15 mo ago | 21 21 → 23 (+10%) · sector median -4% | 2017 | Seth Flam Co-Founder & CEO | — | — |
| 22 | Creyon Bio Provider of drug design and oligonucleotide-based drug development platform | $40M | 51 mo ago | 38 | 2019 | Swagatam Mukhopadhyay Chief Scientific Officer & Cofounder & Board Member | — | — |
| 23 | BetterNight Provider of app and assesments for sleep improvement | $39M | 39 mo ago | 350 | 1995 | Dave French Founder & CEO | — | — |
| 24 | Faro Health Provider of cloud-based clinical trials management tool for a healthcare organization | $38M | 40 mo ago | 20 | 2019 | Scott Chetham Co-Founder & CEO | — | 1 job opening |
| 25 | Inocras AI-driven platform provides whole genome insights for cancer and rare diseases | $30M | 18 mo ago | — | 2020 | Jeong Lee Co-Founder & Chief Innovation Officer | — | — |
| 26 | Function Oncology Developer of therapeutics to treat cancer | $28M | 38 mo ago | 16 | 2018 | Christian Schmedt Co-Founder | 9 patents Functional genomic profiling of cancers using CRISPR-based personalized screening | — |
| 27 | VivoSense Wearable sensor CRO providing precision insights for clinical trials | $27M | 51 mo ago | 49 | 2010 | Lance Myers Co-Founder | — | — |
| 28 | Condor Software-based financial management platform for clinical industries 29Funding top 27%News top 29%Talent top 38%Tech top 45% All 9 signals ▾Fundingtop 27% Newstop 29% Talenttop 38% Techtop 45% Moattop 48% Innovationbottom 46% Productbottom 45% Globalbottom 32% Marketbottom 21% Funding: Raised $24.0M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) News: 3 BI events in 12 mo (of 5 tracked, 3 types) · +200% YoY rank vs industry peers · Fliar Intelligence Index 29/100 | $24M | 3 mo ago | 8 | 2003 | John Sammataro Co-Founder | — | — |
| 29 | Independa Elderly care using remote monitoring | $24M | 20 mo ago | 3 | 2009 | Kian Saneii Founder | 8 patents Interactive TV UI integration for second-screen apps and remote care management platforms | 2 partnerships |
| 30 | TARA Mind Digital teleconsultation and booking platform for mental health | $22M | 28 mo ago | 13 | 2022 | Marcus Capone Founder / CEO | — | 1 partnership |
| 31 | Model Medicines Developer of AI-based drug discovery platform | $20M | 7 mo ago | 26 | 2019 | Daniel Haders II Chief Executive Officer | 18 patents Antiviral therapeutics targeting DNA/RNA viruses, including SARS‑CoV‑2, using pipendoxifene. | — |
| 32 | Sinopia Biosciences Data-driven drug discovery using multi-omics, AI, and disease models 13Funding top 28%AI top 45%Global bottom 29%Tech bottom 26% All 5 signals ▾Fundingtop 28% AItop 45% Globalbottom 29% Techbottom 26% Marketbottom 16% Funding: Raised $19.4M across 13 rounds · 13 rounds over 5 yrs (2.6/yr) AI: Product described with: machine learning rank vs industry peers · Fliar Intelligence Index 13/100 | $19M | 2 mo ago | 4 | 2014 | — | — | — |
| 33 | Cortechs.ai Provider of AI-powered medical imaging analysis software | $17M | 11 mo ago | 24 | 2001 | Anders Dale Founder | 23 patents Patents concentrated in computing, sensing & instrumentation | 1 partnership |
| 34 | Livara Provider of an orthopedic care management platform for healthcare payors and providers | $15M | 25 mo ago | 11 | 2022 | Kamshad Raiszadeh Chief Medical Officer & Founder | — | — |
| 35 | Rejuvenate Bio Developer of gene therapies for treating chronic and age-related diseases | $15M | 23 mo ago | 39 | 2018 | Noah Davidsohn Co-Founder & CSO | — | — |
| 36 | Vessel Provider of a personalized mobile app and test kit for tracking nutrition | $14M | 44 mo ago | 32 | 2015 | Jon Carder Co-founder | 19 patents Advanced natural gas purification and processing technologies for fluid treatment applications. | — |
| 37 | Aizen Therapeutics Provider of AI-based platfrom for drug development | $13M | 18 mo ago | — | 2022 | Ajay Kshatriya CEO | — | — |
| 38 | EdgeX SaaS-based inventory tracking system for hospitals | $8M | 14 mo ago | 9 | 2018 | Tim Gibbons CEO | — | 3 launchs |
| 39 | Modulo AI-powered drug development platform to treat neurological conditions | $8M | 19 mo ago | 16 | 2021 | Michael Horowitz Co-Founder & CEO | — | — |
| 40 | Xifin Cloud-based billing & revenue cycle management solutions for diagnostic service providers | $6M | 9 mo ago | 861 861 → 719 (-16%) · sector median -4% | 1997 | Lale White Executive Chairman and CEO | 4 patents AI-powered multimodal medical image analysis and automated diagnostic recommendation with visual annotation | 2 internships |
| 41 | FuturHealth Platform offering weight loss medication and support services | $5M | 30 mo ago | — | 2017 | John Levan Co-Founder & Owner | — | 1 launch |
| 42 | ISHI AI-powered virtual clinic specializing in heart failure and complex cardiac disease care | $4M | 27 mo ago | — | 2022 | Ajay Srivastava Founder & CEO | — | — |
| 43 | Persperion Diagnostics Developer of medical device fo sweat analysis | $4M | 13 mo ago | 4 | 2022 | Xinyu Liu Co-Founder | — | — |
| 44 | rightdevice Provider of patient portal software for surgeons | $4M | 23 mo ago | — | 2011 | — | 2 patents Processing and managing medical implant device data and patient health information | — |
| 45 | CARI Health Digital remote medication monitoring tool for providers | $2M | 11 mo ago | 6 | 2015 | Patrik Schmidle Co-Founder & CEO | — | — |
| 46 | Quasar Innovating dry EEG sensors and psychophysiological monitoring systems for diverse applications | $1M | 16 mo ago | — | 1997 | Walid Soussou CEO | 7 patents Patents concentrated in health & consumer products | — |
| 47 | Advanced Brain Monitoring Provider of neuro-diagnostics devices for researchers and clinical trials | $1M | 9 mo ago | 41 | 1997 | — | 104 patents Neurodegenerative diagnostics, brain‑targeted personalized therapy, and precise positioning systems for neurosurgery | — |
| 48 | Biocanic Provider of solution for decision making through clinical analysis | $750K | 17 mo ago | 7 | 2018 | Jeremy Malecha CEO | — | — |
| 49 | Powell Mansfield Developer of AI-powered point-of-care sleep apnea diagnostic platform | $616K | 21 mo ago | — | 2014 | Perry Mansfield Founder | 30 patents EMG and neuromuscular sensing technologies for diagnostic and monitoring devices | — |
| 50 | Abterra Biosciences Platform for antibody sequencing and analysis | $200K | 15 mo ago | 9 | 2009 | — | — | 1 launch |
Top 12 HealthTech companies in San Diego
#1
Series C · San Diego, California · founded 2019 · 50 employees$206.2Mraised▾
Provider of AI-driven drug discovery platform for the treatment of cancer. It offers an AI driven discovery platform and has discovered two candidates known as IAM-H1, a highly selective and brain penetrant inhibitor of HER2 and its oncogenic mutants, and IAM-C1 a potential first-in-class selective dual CDK2/4 inhibitor to address unmet needs in terms of therapeutic window and treatment resistance in cell cycle driven cancers.
- Apr 2026Series C$27.8M
- Nov 2025Series C$100M
- Apr 2024Series B$50M
- Oct 2023Series B$103.2M
#2
Series C · San Diego, California · founded 2020 · 52 employees$55Mraised▾
Online platform for employee health benefits. The company has designed an online platform that enlists prices of different medical expenses, insurances, and healthcare plans for patients, providers, and employees to browse through. Users can browse medical expenses based on a particular surgery. diagnosis, treatment, or medical organization. Payers can use the platform to let patients compare insurance rates and calculate estimates. Providers can benchmark rates against the market by comparing other rates, hospitals are allowed to patients browsing experience of services with prices on the platform, and employees can go through healthcare claims.
- Mar 2026Series C$40M
- Jan 2024Series B$30M
- May 2022Series A$20M
- Jul 2021Seed$5M
#3
Funding Raised · San Diego, California · founded 2014 · 4 employees$19.4Mraised▾
Data-driven drug discovery using multi-omics, AI, and disease models. The company is transforming drug discovery by applying high-throughput multi-omics data, AI/machine learning, network analyses, and disease models to identify novel targets and mechanisms. Their LEADS® platform combines high-throughput screening, multi-omics data, AI, and network analyses to accelerate the discovery of first-in-class therapeutics. They focus on areas with high clinical unmet need, including neurology, oncology, and genetic diseases. By leveraging advances in metabolomics technologies and computational data analysis, they study diseases and compounds at an unprecedented level of biomolecular detail. This approach enables superior predictivity and facilitates the development of innovative medicines. The company collaborates with leading groups to explore therapeutic areas, offering a data-driven approach to advance drug discovery efforts.
- Mar 2026Grant (prize money)—
- Dec 2025Grant (prize money)—
- May 2025Grant (prize money)$318.3K
- Sep 2024Grant (prize money)$2.2M
#4
Series A · San Diego, California · founded 2003 · 8 employees$24Mraised▾
Software-based financial management platform for clinical industries. It automates and manages clinical accruals, financial insights, cash planning, accruals, financial planning, analytics, audits, scenario cash planning, and more. It also offers solutions for vendor management, document management, and more.
- Mar 2026Series A$24M
#5
Series C · San Diego, California · founded 2012 · 91 employees$175.1Mraised▾
Provider of a wearable biosensor platform for diabetes monitoring. It offers a wireless microsensor that enables users to understand their metabolism and blood glucose levels in real-time.
- Mar 2025Series C$100M
- Dec 2023Series B$59.1M
- Nov 2021Series B$100M
- Sep 2021Grant (prize money)$1.9M
#6
Series A · San Diego, California · founded 2019 · 26 employees$19.8Mraised▾
Developer of AI-based drug discovery platform. The company focuses on therapeutics for gastric disorders, neurological disorders, weight disorders, and infectious diseases. Also, uses the collection of drug development data, a drug and disease agnostic discovery platform along with AI to develop drugs.
- Oct 2025Series A$3.3M
- Sep 2024Series A$14.8M
- Dec 2023Series A$950K
- Apr 2022Series A$489K
#7
Series B · San Diego, California · founded 2013 · 85 employees$408.7Mraised▾
Provider of precision medicine, preventative health assessments, and longevity care. The company offers comprehensive health assessments to detect life-threatening conditions early. It focuses on data-driven, personalized healthcare designed to uncover health risks. The company provides services to help individuals take control of their health.
- Aug 2024Series B$39.8M
- Mar 2023Series B$32M
- Oct 2022Series B$6.9M
- Jul 2019Series B$30M
#8
Series C · San Diego, California · founded 2001 · 24 employees$16.9Mraised▾
Provider of AI-powered medical imaging analysis software. This software offers automated segmentation and volumetric analysis of brain and prostate images, supporting improved diagnosis and monitoring of neurological and oncological diseases. The solutions enhance radiology workflows and provide quantitative insights to clinicians. Specific applications include brain tumor analysis, multiple sclerosis lesion tracking, and prostate MRI optimization. The software is designed to improve the accuracy and timeliness of diagnostic decisions.
- Jul 2025Grant (prize money)$1.3M
- Nov 2024Series C—
- Jul 2024Grant (prize money)—
- Jul 2024Grant (prize money)$295.8K
#9
Series B · San Diego, California · founded 2017 · 21 employees$43.9Mraised▾
Decision support solutions for healthcare professionals. The solutions offered by the company include ForeSee ESP, Rule Builder, ForeSee Predictor, ForeSee Quality Director, ForeSee Analyzer, risk stratification tool, and communicator.
- Feb 2025Series B$2M
- Apr 2024Series B$4.9M
- Feb 2024Series A$500K
- Apr 2023Series A$4M
#10
Series C · San Diego, California · founded 2015 · 106 employees$206.1Mraised▾
Developer of automated benchtop blood testing system for labs. The company has developed a patented diagnostic platform, that enables comprehensive blood testing using chemistries, immunoassays, and hematology assays using a small sample of blood.
- Jul 2024Series C$74M
- Sep 2021Conventional Debt$25M
- Feb 2021Series C$105M
- Nov 2019Series B$27.1M
#11
Acquired · San Diego, California · founded 1997 · 861 employees$6Mraised▾
Xifin is a cloud-based billing & revenue cycle management solutions for diagnostic service providers. It features a business intelligence platform to link healthcare stakeholders in the delivery and reimbursement of care and optimizes both business and patient outcomes. It offers to increase in patient payments, reduces errors in billing data, improves staff productivity and streamline revenue cycle management, enhances patient satisfaction, and reduce bad debt and billing costs.
- Sep 2025Series B—
- 2004Conventional Debt—
- Oct 2001Series A$6M
#12
Series B · San Diego, California · founded 2020$29.7Mraised▾
AI-driven platform provides whole genome insights for cancer and rare diseases. It has developed an IP-protected technology and proprietary whole genome insight platform to improve patient diagnosis and treatment by unlocking the full potential of genomic data.
- Dec 2024Series B—
- Nov 2023Series B$23M
- 2020Seed$400K
- 2020Grant (prize money)$300K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of HealthTech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Digital Health is moving in the United States
A read on the academic research around Digital Health — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 8,843 United States-affiliated papers.
- Design Intelligence421
- Harvard University383
- Johns Hopkins University295
- University of North Carolina at Chapel Hill206
- University of Washington173
- Health care9→240
- Wearable computer6→129
- Health informatics25→140
- Remote patient monitoring11→76
- Informatics10→60
- Health care36→766
- Health informatics113→495
- Psychological intervention20→320
- Public health34→290
- Intervention (counseling)5→193
- Health care98→1170
- Health informatics213→712
- Public health73→525
- Psychological intervention26→368
- Health administration110→363
Where digital health is researched across United States
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing medical devices patents in the United States
United States medical devices patent filing is accelerating — 666,693 filings from 8,000 assignees (2016–2025), led by Covidien, Boston Scient Scimed, Medtronic; annual filings 63466→63610.
- Covidien29351
- Boston Scient Scimed24775
- Medtronic22434
- Becton Dickinson18269
- Procter & Gamble16210
- Ethicon ENDO Surgery13758
- Kimberly Clark12462
- Ethicon11769